Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from TARA

'A free mind equals fast legs' – How my mental state helped me wear the yellow jersey for two days at an unforgettable Tour Auvergne-Rhône-Alpes

In Luke Tuckwell's latest column for Cyclingnews, he recalls his memorable week in France, and how he went from tears in training to his first yellow jersey

Cycling News · Jun 30

I Dream of Theresa May review – willing immigrant’s political conversion spurs stiff debate

A young, gay Indian man learns steps to Britishness from a phantom vision of the Tory politician, but the result is less sinister a satire than it should be

The Guardian - UK · Nov 23, 2025

2 Stocks Under $10 Wall Street Says Are 'Strong Buys'

You can spend less and earn significant returns with these two cheap stocks.

Barchart · May 28, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Israeli Group Belong.Life Launches Tara, A Conversational AI Platform For Cancer Clinical Trial Matching

Belong.Life's AI Chatbot Tara Simplifies Cancer Clinical Trial Matching and Recruitment

Zenger · Sep 28, 2023

Apparel brand Jade opens two new stores in Delhi’s Mehrauli to mark 15th anniversary

After 40 years of consistent, creative, committed and patient work, Monica and Karishma have taken India's finest craft and skill set to the world. Their new collection, 'Tara', features bridal ensembles, western couture and vintage pieces. They also have a Chanakya school of embroidery to teach women. Their emblem, two…

The Hindu · Sep 1, 2023

Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations

Protara Therapeutics Inc (NASDAQ:TARA) announced the results of a retrospective analysis of OK-432, the originator compound for TARA-002, its investigational therapy in development for lymphatic malformations (LMs), rare, congenital malformations of lymphatic vessels. The results from the analysis showed that OK-432 was clinically successful and generally well-tolerated in the treatment of both macrocystic…

Benzinga · May 12, 2022

Recap: Protara Therapeutics Q1 Earnings

Protara Therapeutics (NASDAQ:TARA) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

Read news from The Economist, FT, and more,
with one subscription

Recap: Protara Therapeutics Q4 Earnings

Protara Therapeutics (NASDAQ:TARA) reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 9, 2022

Coverage From

People

Tobias Halland Johannessen

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.